Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
09-Apr-2025 | 4,895 | 4,938.35 | 4,826.65 | 4,884.9 | 12,691 | 39,64,56,200.75 | 59,985 |
11-Apr-2025 | 4,900 | 5,016.7 | 4,852.5 | 4,957.45 | 24,477 | 46,27,62,980.8 | 43,316 |
15-Apr-2025 | 5,097 | 5,123.5 | 4,940.1 | 5,059.4 | 23,063 | 71,26,72,326.8 | 95,955 |
16-Apr-2025 | 5,050.6 | 5,109.9 | 5,024.1 | 5,050.9 | 12,018 | 34,24,04,404.1 | 46,174 |
17-Apr-2025 | 5,037.5 | 5,084 | 5,006.8 | 5,060.8 | 13,818 | 30,49,09,680.4 | 39,013 |
21-Apr-2025 | 5,062 | 5,100 | 4,985 | 5,054.6 | 13,016 | 36,92,01,806.1 | 47,471 |
22-Apr-2025 | 5,053 | 5,214 | 5,014 | 5,151.9 | 34,562 | 84,09,48,261.5 | 94,340 |
23-Apr-2025 | 5,151.9 | 5,232.9 | 4,960 | 5,081.6 | 13,596 | 24,29,29,615.8 | 20,735 |
24-Apr-2025 | 5,116.3 | 5,297.3 | 5,106.3 | 5,262 | 41,465 | 1,81,02,83,542.3 | 2,20,916 |
25-Apr-2025 | 5,262 | 5,323 | 5,181.1 | 5,245.3 | 15,653 | 38,09,83,226.8 | 24,823 |
28-Apr-2025 | 5,275.3 | 5,275.9 | 5,088.7 | 5,124.6 | 15,594 | 31,14,98,388 | 32,782 |
29-Apr-2025 | 5,125 | 5,195.7 | 5,040 | 5,152.4 | 11,485 | 23,42,00,883.7 | 16,724 |
30-Apr-2025 | 5,132 | 5,158.6 | 5,062.8 | 5,112.7 | 12,335 | 30,52,15,720.6 | 38,649 |
02-May-2025 | 5,107 | 5,188 | 5,103.5 | 5,162 | 12,491 | 33,22,47,638 | 45,331 |
05-May-2025 | 5,135 | 5,213 | 5,096.5 | 5,160.5 | 14,369 | 23,92,80,874.5 | 27,211 |
06-May-2025 | 5,160.5 | 5,194 | 5,050 | 5,104.5 | 6,604 | 13,85,29,424.5 | 15,667 |
07-May-2025 | 5,003 | 5,100 | 5,000.5 | 5,048.5 | 9,896 | 14,84,95,556.5 | 16,388 |
08-May-2025 | 5,016 | 5,110 | 5,016 | 5,061.5 | 14,120 | 25,04,41,542.5 | 30,948 |
The proposed issuance of ₹500 crore of NCDs may be done in one or more tranches over a period of 12 months from the date of the AGM.
Here are some of the stocks that may see significant price movement today: GAIL, Zydus Lifesciences, Aurobindo Pharma, etc.
Sales volume dropped by 4.54% at 22.48 lakh tonnes for these three months.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Capacity utilization for Q2 FY25 was 64% for cement production and 67% for clinker, influenced by operational disruptions at the Muddapur facility.
The sales target for the paints division in FY 2024-25 is set between ₹250-300 Crore, according to Anuj Khandelwal, Business Head of Grey Cement Division.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
